Refractive Surgery
Wavefront-guided LASIK safe and effective for patients with thin corneas
Published in Medical Devices and Surgical Technology Week, October 16th, 2005
Ophthalmologists in Israel conducted a study "to evaluate the clinical outcome of wavefront-guided laser in situ keratomileusis (LASIK) for the treatment of moderate to high myopia associated with a thin cornea."
"This retrospective study included 98 eyes of 49 patients with moderate to high myopia (-5.20 to -10.35 diopters [D]) and thin corneas (456 to 498 microm) treated with wavefront-guided LASIK (Zyoptix, Bausch & Lomb) and followed for 36 months," explained I. Kremer and coauthors at the Rabin Medical Center. "Preoperative wavefront analysis was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Colonoscopy
Magnetic endoscope locating device useful - Coronary Artery Bypass
Minimized extracorporeal bypass system lacks clinical benefit - Cystic Fibrosis
Novel test improves molecular screening in ethnically diverse populations - Diagnostics
High-quality endoscopic recording/monitoring system developed - Glaucoma Therapy
Baseline IOP predicts selective laser trabeculoplasty outcome - Acute Renal Failure
Continuous and intermittent RRT have comparable outcome - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
